[1] [1] SHAN Tiliang, ZHANG Xuexin, MA Shuran, et al. Progress in TCM treatment of hyperlipidemia［J］. Chinese Medicine, 2014, 9(12): 1870-1872.

[2] [2] YANG Z, ZHOU E, WEI D, et al. Emodin inhibits LPS-induced inflammatory response by activating PPAR-γ in mouse mammary epithelial cells［J］. International Immunopharmacology, 2014, 21(2): 354-360.

[3] [3] TIAN S L, YANG Y, LIU X L, et al.Emodin attenuates bleomycin-induced pulmonary fibrosis via anti-inflammatory and anti-oxidative activities in rats［J］. Medical Science Monitor, 2018, 24(1): 1-10.

[4] [4] LI L, SONG X, YIN Z, et al.The antibacterial activity and action mechanism of emodin from polygonum cuspidatum against haemophilus parasuis in vitro［J］. Microbiological Research, 2016, 186(1): 139-145

[5] [5] LI B H, HUANG Y Y, DUH P D, et al.Hepatoprotection of emodin and polygonum multiflorum against CCl(4)-induced liver injury［J］. Pharmaceutical Biology, 2012, 50(3): 351-359.

[6] [6] SHRIMALI D, SHANMUGAM M K, KUMAR A P, et al.Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer［J］. Cancer Letters, 2013, 341(2): 139-149.

[7] [7] WU J H, WANG Q H, LI F, et al.Suppression of diet-induced hypercholesterolemia by turtle jelly, a taditional chinese functional food, in rats［J］. Evidence-Based Complementary and Alternative Medicine, 2012, 2012(1): 1-15.

[8] [8] CHEN Hanzhu, LIN Guowei, WANG Jiyao.Practical internal medicine［M］. Beijing: People’s Medical Publishing House,2013: 33.

[9] [9] WANG Shuyan, LI Ruiqi, SU Haixia.Six cases of simvastatin related liver impairment［J］. Central South Pharmacy, 2018, 16(8): 1164-1166.

[10] [10] TANG Wei.Analysis of side effects of simvastatin in the treatment of 34 cases of coronary heart disease complicated with hyperlipidemia［J］. China Practical Medical, 2013, 8(2): 51-52.

[11] [11] YANG Zhen, MA Xiaozhi, MA Yi, et al.Analysis of adverse drug reactions induced by the combined use of statin lipid lowering drugs and other drugs［J］. Internal Medicine, 2018, 13(2): 181-184.

[12] [12] ZHAO Xiaoling, WANG Ming.Analysis of 185 cases of statin-induced ADR in lipid-lowering therapy in our hospital［J］. China Pharmacy, 2016, 27(2): 204-206.

[13] [13] HAO Zijuan, MA Hua.Advances in TCM treatment of hyperlipidemia［J］. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular disease, 2015,13(17): 1950-1952.

[14] [14] WANG Yijun, FENG Shuhan, CHENG Jintang, et al.Research progress on chemical constituents and pharmacological action of anthraquinone in Rhei Radix et Rhizoma［J］. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(13): 227-234.

[15] [15] CHENG Long, DONG Shifen, YUAN Yueying, et al.Effect of emodin on adipose browning in ApoE knockout mice［J］. Chinese Journal of Comparative Medicine, 2018, 28(11): 11-17.

[16] [16] FAN Baoyan, ZHU Haibo.Improvement of emodin for lipid metabolism disorder in hyperlipidemia hamster［J］. China Medical Herald, 2014, 11(24): 4-8.

[17] [17] LI Sha, GUO Yuanlin, ZHAO Xi, et al.Novel and traditional lipid-related biomarkers and their combinations in predicting coronary severity［J］. Scientific Reports, 2017, 7(1): 1-10.

[18] [18] YANG Xuesong, SUN Fenyong, LI Zebing, et al.Role of nitric oxide, endothelin-1 and homocysteine for the auxiliary diagnosis of coronary heart disease［J］. Laboratory Medicine, 2018, 33(4): 316-320.

[19] [19] LI Yuanyuan, WANG Qi.Clinical application of homocysteine and vascular endothelial function determinations in cerebral infarction［J］. Laboratory Medicine, 2014, 29(10): 1028-1030.

[20] [20] CHAN E, CHAN Y Y, WU J H, et al.Serum nitric oxide synthase activity is a novel predictor of impaired vasorelaxation in rats［J］. Clinical & Experimental Pharmacology & Physiology, 2012, 39(10): 894-896.

[21] [21] SUN Ting, CHI Qingjia, WANG Guixue.Research progress of NO3 participation in regulatory mechanisms of cardiovasucular diseases［J］. Journal of Biomedical Engineering, 2016, 33(1): 188-192.